ASH, the world's largest professional society concerned with the causes and treatments of blood disorders, regularly issues press releases highlighting clinical and research advances announced at the ASH annual meeting and published in Blood, as well as releases and statements on breaking policy news affecting the field of hematology.
News and Press Releases
Hereditary Mutations in BRCA Genes Increase Risk of Rare Lymphoma Among Women with Breast Cancer Who Received Textured Breast Implants
June. 13, 2025
ASH Commits More than $12 Million to Address Research Threats
June. 10, 2025
ASH Statement on Proposed Budget Cuts to the National Institutes of Health
Jun. 6, 2025
ASH and ISTH Publish Revised Clinical Practice Guidelines for Pediatric Venous Thromboembolism
May. 27, 2025
Statin Use May Improve Survival for Some Blood Cancers
Apr. 23, 2025
Real-World Study Finds Hydroxyurea Effective Long-Term in Children Living with Sickle Cell Disease
Apr. 17, 2025
Menstrual Cycle May Contribute to Sickle Cell Disease Pain Crises
Apr. 9, 2025
ASH Statement on Restructuring and Mass Layoffs Announced at the U.S. Department of Health and Human Services
Mar. 28, 2025
Machine Learning Program Enhances Transplant Risk Assessment in Myelofibrosis Patients Better Than Current Models
Mar. 27, 2025
ASH Significantly Expands Bridge Grant Eligibility
Mar. 20, 2025
No Scientific Link Found Between Sickle Cell Trait and Sudden Death
Jan. 30, 2025
American Society of Hematology Announces 2025 Scholar Award Recipients
Jan. 17, 2025
Belinda Avalos, MD, Begins Term as 2025 ASH President
Jan. 7, 2025
Heightened Risk of Hospitalization for Blood Clots Seen in People with Long-Term Exposure to Air Pollution
Dec. 17, 2024
Stem Cell Transplant Offers No Additional Benefit for Patients with Mantle Cell Lymphoma in Deep Remission
Dec. 10, 2024
Undergoing Stem Cell Transplant for Sickle Cell Disease in Childhood Improves Quality of Life a Decade Later
Dec. 10, 2024
Genetic Profile Correlates with Better Response to Treatment for Myeloproliferative Neoplasms
Dec. 10, 2024
ASH Identifies Strategies and Barriers for Implementing DEI in Clinical Trials
Dec. 9, 2024
ASH Newborn SCD Screening Program in Sub-Saharan Africa Found Feasible
Dec. 8, 2024
Studies Highlight Progress in Preventing and Treating Blood Cancers and Pre-Cancerous Conditions
Dec. 8, 2024
Universal Duffy Testing is Likely Cost Effective for U.S. Population
Dec. 7, 2024
Disease-Modifying Therapies Remain Underused in SCD Despite Safety and Efficacy
Dec. 7, 2024
Researchers Report New Opportunities to Improve Quality of Life for People with Non-Malignant Blood Disorders
Dec. 7, 2024
Studies Highlight Interactions Among Lifestyle Factors, Disease Development, and Response to Treatment
Dec. 7, 2024
Putting Women and Children First to Optimize Their Hematology Health
Dec. 7, 2024
#Fight4Hematology Action Hub
As the world’s largest professional society serving clinicians and scientists around the world who are working to conquer blood diseases, ASH is fighting for hematology in the face of executive orders and other federal actions that threaten hematology research and, ultimately, the care of patients.
Take Action
Protect Medical Research
Urge your members of Congress to support continued medical research funding.